Obeticholic Acid is a farnesoid X receptor agonist indicated for treating primary biliary cholangitis, an autoimmune liver disease. It helps improve liver function by reducing bile acid synthesis and promoting bile flow, thus alleviating symptoms and preventing disease progression. By modulating bile acid metabolism, Obeticholic Acid plays a crucial role in managing liver health in affected patients. In summary, it is an essential therapy for managing liver conditions related to bile acid dysregulation.
Obeticholic Acid activates the farnesoid X receptor (FXR), leading to reduced bile acid synthesis and increased bile acid excretion, improving liver function.





